Improving Access to Care for Rural Veterans Act

The 'Improving Access to Care for Rural Veterans Act' (S3033) has been ordered to be reported favorably with an amendment in the nature of a substitute by the Committee on Veterans' Affairs. This legislative action signifies a direct move towards enhancing healthcare services for veterans in rural areas. The bill's progression through committee indicates strong legislative momentum and a high probability of further advancement, leading to increased federal expenditure in this specific healthcare segment. Funding for this initiative will flow through the Department of Veterans Affairs (VA) to healthcare providers, pharmaceutical companies, and medical device manufacturers. The mechanism will involve expanded VA contracts for services, procurement of medications, and medical equipment specifically aimed at rural veteran populations. Companies with established supply chains and service networks in rural regions are positioned to capture these contracts. This includes major pharmaceutical companies like Viatris ($VTRS), Merck ($MRK), Pfizer ($PFE), and Johnson & Johnson ($JNJ), which supply essential medicines. Healthcare service providers such as CVS Health ($CVS) and Walgreens Boots Alliance ($WBA), through their pharmacy and clinic networks, and managed care organizations like UnitedHealth Group ($UNH) and Enhabit Home Health & Hospice ($EHR), which provide home health services, will see increased demand and contract opportunities. A historical precedent for increased veteran healthcare spending occurred with the VA MISSION Act of 2018. This act expanded veterans' access to community care providers. Following its implementation, companies like TriWest Healthcare Alliance (a private company, but its partners saw increased patient volumes) and various community healthcare providers experienced a measurable increase in patient referrals and associated revenue. While direct public market data for the 2018 act's immediate impact on specific publicly traded companies is complex due to broader market conditions, the underlying principle of expanded access leading to increased demand for services and products holds true. For example, companies providing telehealth services, which were a component of expanded access, saw sustained growth. Specific winners include pharmaceutical companies like Viatris ($VTRS) due to its focus on generics and biosimilars, Merck ($MRK) and Pfizer ($PFE) for their broad drug portfolios, and Johnson & Johnson ($JNJ) for medical devices and pharmaceuticals. Healthcare service providers such as CVS Health ($CVS) and Walgreens Boots Alliance ($WBA) will benefit from increased prescription fulfillment and clinic visits. UnitedHealth Group ($UNH) and Enhabit Home Health & Hospice ($EHR) are positioned to gain from expanded managed care and home health services for rural veterans. There are no direct losers identified, as the bill expands access rather than restricting it. The next step for S3033 is consideration by the full Senate. If passed by the Senate, it will move to the House of Representatives for consideration. Given its favorable reporting from committee, the bill has a strong chance of passing both chambers and becoming law within the next 6-12 months, leading to implementation and contract awards shortly thereafter.